logo
15:59 Dec 05

Alembic Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
100.85
-1.89 (-1.84%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alembic Ltd. Financials

Alembic Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
100.85
-1.89 (-1.84%)
15:59 Dec 05
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

49/100
Technically Neutral

Strength

14

Weakness

3

Opportunity

0

Threats

0

13.28 %

ROE %

12.41 %

ROA %

12.62

EPS

91.07

BVPS

140.01 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
78.22 127.24 157.49 221.89 220.85
Operating Expenses +
64.29 86.91 100.62 128.18 127.94
Raw Material
8.53 6.92 8.62 8 8.59
Increase Decrease in Cost
2.46 -0.6 0.53 1.11 1.54
Other Manufacturing Expense
11.64 34.8 39.81 60.05 0
Employee Cost
21.47 24.04 23.03 27.31 27.41
Miscellaneous Expenses
20.19 21.75 28.63 31.71 90.4
Operating Profit
13.93 40.33 56.87 93.71 92.91
Other Income
89.18 64.26 54.77 74.89 76.52
Depreciation
4.86 6.72 7.84 10.63 10.91
Interest
0.39 0.47 1.11 2.47 2.57
Profit before tax and exceptio..
97.86 97.41 102.69 155.5 155.95
Exceptional Items
0 -10.61 0 0 0
PBT
97.86 86.8 102.69 155.5 155.95
Provision for Taxation
11.66 6.18 9.82 10.93 10.97
Net Profit
86.19 80.62 92.87 144.57 144.96
NET Profit after MI
222.06 190.65 268.62 310.68 316.51
EPS
8.65 7.42 10.46 12.1 12.33
Operating Profit Margin (%)
17.81 31.7 36.11 42.23 42.07
Net Profit Margin (%)
283.89 149.84 170.56 140.02 143.31

Alembic Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 70.90 70.90 70.90 70.90 70.90 70.90
FII 1.40 1.50 1.60 1.80 2.00 1.40
Public 0.00 0.10 0.10 0.00 0.10 0.10
Others 27.70 27.50 27.40 27.30 27.00 27.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: